Inner Banner

Publications

    • Bajpai J, Simha V, Shylasree TS, Sarin R, Pathak R, Popat P, Mokal S, Dandekar S, Ghosh J, Nair N, Gulia S, Rath S, Joshi S, Wadasadawala T, Sheth T, Parmar V, Banavali SD, Badwe RA, Gupta S (2021). Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India. Breast. 56: 88-95. PMID: 33640524
    • Bandekar B, Awatagiri K, Kannan S, Rane P, Parikh P. Audit of principal investigator's compliance for submission of continue review application and decisions taken on lapses in validity of approval by the Institutional Ethics Committee at tertiary oncology center in Navi Mumbai. Perspectives in Clinical Research
    • Barange M, Epari S, Gurav M, Shetty O, Sahay A, Shetty P, Goda J, Moiyadi A, Gupta T, Jalali R (2021). TERT promoter mutation in adult glioblastomas: It's correlation with other relevant molecular markers. Neurology India. 69:126-34. PMID: 33642283
    • Bhagatram J, Krishamurthy MN, Awase A, Joshi A,Patil V, Noronha V, Prabhash K, Gota V. Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy. Therapeutic Advances in Drug Safety. PMID: 33628419
    • Borah P, Mirgh S, Sharma S, Bansal S, Dixit A, Dolai T, Lunkad S, Gupta N, Singh G, Jain A, Bansal D, Choudhary D, Khandelwal V, Doval D, Kumar M, Bhargava R, Chakrabarti A, Kalashetty M, Rauthan A, Kazi B, Mandal P, Jeyaraman P, Naithani R. AIIMS Hematology Alumni Group. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. Blood Cells, Molecules, and Diseases. 87: 102525. PMID: 33338697
    • Chatterjee G, Dudakia V, Ghogale S, Deshpande N, Girase K, Chaturvedi A, Shetty D, Senger M, Jain H, Bagal B, Bonda A, Punatar S, Gokarn A, Khattry N, Patkar NV, Gujral S, Subramanian PG, Tembhare PR (2021). Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment. International Journal of Laboratory Hematology. PMID: 33432783.
    • Chilukuri S, Murthy V(2021) . Adjuvant radiation for prostate cancer: Too early to abandon? BJU International. PMID: 33834591
    • Chopra S, Mangaj A, Sharma A, Tan LT, Sturdza A, Schulz I, Han K, Huang F, Schmid M, Fokdal L, Chargari C, Diendorfer T, Tanderup K, Potter R, Nout R (2021). Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network 155: 151-159. Radiotherapy and Oncology. PMID: 33144247
    • D'Cruz A, Dhar H, Vaish H, Vaish R, Hawaldar R, Gupta S, Pantvaidya G, Chaukar D, Chaturvedi P, Pai P, Deshmukh A, Kane S, Nair D, Nair S, Ghosh-Laskar S, Agarwal J (2021). Depth of invasion in early oral cancers- is it an independent prognostic factor? European Journal of Surgical Oncology. PMID: 33814237
    • Deshpande G, Epari S, Gupta C, Shetty O, Gurav M, Chinnaswamy G, Gupta T (2021). Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Child's Nervous System. 37(3):839-849. PMID: 32761378
    • Forester R, Zwahlen D, Buchali A, Tang H, Schroeder C, Windisch P, Vu E, Akbaba S, Bostel T, Sparve T, Zamboglou C, Zilli T, Stelmes J-J, Telkhade T, Murthy V (2021). Stereotactic body radiotherapy for high-risk prostate cancer: A systematic review. Cancers. 13(4):759. PMID: 33673077
    • Ganesan P, Jain H, Bagal B, Subramanian PG, George B, Korula A, Mehra N, Kalaiyarasi JP, Bhurani D, Agrawal N, Ahmed R, Kayal S, Bhattacharyya J, Yanamandra U, Kumar S, Philip CC, John MJ, Nadaraj A, Karunamurthy O, Lakshmanan J, Mathews V, Sengar M (2021). Outcomes in adolescent and young adult acute lymphoblastic leukaemia: A report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC). British Journal of Haematology. PMID: 33656752
    • Ghosh J, Joy Phillip DS, Ghosh J, Bajpai J, Gulia S, Parmar V, Nair N, Joshi S, Sarin R, Budrukkar AN, Wadasadawala T, Desai SB, Shet T, Patil A, Sawant SP, Dhir AA, Kembhavi S, Popat P, Hawaldar R, Kembhavi Y, Perumal P, Banavali SD, Badwe RA, Gupta S. Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer. Indian Journal of Cancer. PMID: 33753616
    • Gota V, Nookala M, Bonda A, Karanam A, Shriyan B, Kembhavi Y, Gurjar M, Patil A, Singh A, Goyal N, Gupta S (2021). Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer. Cancer Medicine. PMID: 33826243
    • Gulia S, Gupta S (2021). Subgroup Analysis from SOLO1 Trial. Journal of Clinical Oncology. 39(3):255. PMID: 33326258
    • Gupta A, Ojha S, P Nagaraju, Poojary M, Sumathi SH, Sathyan V, Ansari A (2021). Impact of the Novel Coronavirus Disease and Lockdown on the Packed Red Blood Cells Inventory Management: An Experience from a Tertiary Care Oncology Center in Western India. Hematology, Transfusion and Cell Therapy. PMID: 33521581
    • Gupta T, Nair S, Chaturvedi P, Agarwal J (2021). Can sentinel lymph-node biopsy become the new standard of care in clinically node-negative neck in early stage oral cancer? European Archives of Oto-Rhino-Laryngology. PMID: 33439341
    • Gupta T, Sinha, S, Chinnaswamy G, Vora T, Prasad M, Bhat V, Goda JS, Krishnatry R, Chatterjee A, Epari S, Sahay A, Moiyadi A, Shetty P, Patil V, Khatua S, Jalali R, Kurkure P. (2021). Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting. Pediatric Blood & Cancer: e28925. PMID: 33533557
    • Gupta T, Maitre M, Maitre P, Goda JS, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali R (2021). High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Clinical and Translational Oncology. PMID: 33528810.
    • Gupta T, Manjali J, Kannan S, Purandare N, Rangarajan V (2021). Diagnostic performance of pre-treatment 18F-fluoro-deoxy-glucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: updated systematic review and diagnostic test accuracy meta-analyses. Clinical Lymphoma Myeloma and Leukemia.
    • Jain H, Shetty D, Moulik N, Narula G, Subramanian PG, Banavali S (2021). A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML. Cancer Genetics. 254-255: 65-69.PMID: 33647813
    • Jain H, Shetty D, Narula G, Roy Moulik N, Tembhare P, Patkar N, Subramanian PG, Banavali S (2020). Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement. Blood Cells, Molecules, and Disease. 88: 102443..PMID: 32414556
    • Jain S, Engineer R, Ostwal V, Ramaswamy A, Chopra S, Desouza A, Lewis S, Arya S, Patil P, Saklani A (2021). Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis. Asia-Pacific Journal of Clinical Oncology. 17:e70-e76.PMID: 32030912
    • Kapoor J, Khushoo V, Garg A, Naim F, Bhatia N, Folbs B, Mehta P, Ahmed R, Agrawal N, Bhurani D, Mirgh SP (2021). An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma. Bone Marrow Transplantation. PMID: 33686246
    • Krishnatry R, Manjali JJ, Chinnaswamy G, Chatterjee A, Goda JS, Janu A, Sahu A, Jalali R, Gupta T (2021). Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma. Japanese Journal of Clinical Oncology. PMID: 33521824.
    • Kulkarni PD, Damle ND, Hingorani L, Bhaskar VH, Ghante MR, Patil A, Gurjar M, Gota V (2021). Pharmacokinetics of solid lipid Boswellia serrata particles in healthy subjects. Drug Metabolism and Personalized Therapy. PMID: 33818023
    • Kumar A, Wadasadawala T, Laskar SG, Gondhowiardjo S, Agarwal JP (2021). Mental health impact of COVID-19 in radiation oncology health care workers of Asian Countries. Clinical Oncology (R Coll Radiol). PMID: 33676823
    • Kumar A, Wadasadawala T, Joshi K, Pathak R, Scaria L, Upreti RR, Bhajbhuje R, Shet T, Parmar V, Gupta S, Mokal S, Sarin R (2021). What is the dosimetric impact of isotropic vs anisotropic safety margins for delineation of the clinical target volume in breast brachytherapy? Brachytherapy. 20: 155-162. PMID: 32888852
    • Lewis S, Chopra S, Singh R, Engineer R (2021). A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India. Indian Journal of Cancer. PMID: 33753598
    • Lewis S, Pandey S, Salins N, Deodhar J, Patil V, Gupta T, Laskar SG, Budrukkar A, Murthy V, Joshi A, Prabhash K, Nair S, Chaturvedi P, Noronha V, Agarwal JP (2021). Distress Screening in Head and Neck Cancer Patients Planned for Cancer-Directed Radiotherapy. Laryngoscope. PMID: 33720420.
    • Loyal A, Chopra S, Goel M, Mehta S, Patil P, Patkar S, Shrivastava S, Engineer R (2021). Predictors of toxicity after neoadjuvant chemoradiotherapy for locally advanced gall bladder cancer. Indian Journal of Cancer. PMID: 33753615
    • Madhugiri V, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Subeikshanan V, Dutt A, Sasidharan G, Kumar V, Ganesh C V Ramesh A, Prabhu A (2021). An analysis of the factors associated with long term survival in patients with glioblastoma. World Neurosurgery. PMID: 33540096
    • Maitre P, Gupta T, Maitre M, Goda J, Krishnatry R, Chatterjee A, Sridhar E, Sahay A, Mokal S, Moiyadi A, Shetty P, Patil V, Jalali R (2021). Prospective longitudinal assessment of quality of life. and activities of daily living as patient-reported outcome measures in recurrent/progressive glioma treated with high-dose salvage re-irradiation. Clinical Oncology (R Coll Radiol). 33(3):e155-e165. PMID: 32917486
    • Mirgh S, Gokarn A, Punatar S, Chichra A, Singh A, Rajendra A, Goli VB, Trivedi B, Joshi A, Patkar N, Tembhare P, Subramanian PG, Shetty N, Chavan P, Bhat V, Gupta S, Khattry N (2021). Clinical Course of Severe COVID19 treated with Tocilizumab and Antivirals Post-Allogeneic Stem Cell Transplant with Extensive Chronic GVHD. Transplant Infectious Disease. PMID: 33523551.
    • Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA (2021). Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. British Medical Journal. 372: n256. PMID: 33627312
    • Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U (2021). Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. Journal of Clinical Oncology. PMID: 33497252
    • Murthy V, Bakshi G, Manjali JJ, Prakash G, Pal M, Joshi A, Dholkia K, Bhattacharjee A, Talole S, Puppalwar A, Srinivasan S, Panigrahi G, Salunkhe R, Menon S, Noronha V, Prabhash K, Krishantry R (2021). Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy. Urologic Oncology: Seminars and Original Investigations. PMID: 33573998
    • Nair NS, Penumadu P, Yadav P, Sethi N, Kohli PS, Shankhdhar V, Jaiswal D, Parmar V, Hawaldar RW, Badwe RA. (2021). Awareness and Acceptability of Breast Reconstruction Among Women With Breast Cancer: A Prospective Survey. JCO global oncology, 7, 253–260. PMID: 33571006
    • Nair NS, Gupta S, Ghosh J, Desai S, Parmar V, Shet T, Chitkara G, Siddique S, Badwe RA (2021). Access to HER2-targeted therapy at a tertiary care center in India: An evolution. Indian Journal of Cancer. PMID: 33753630
    • Narkhede AM, Kothekar AT (2021). Anticipated difficult airway: Planning, safety and ethics while applying a novel technique. Saudi Journal of Anaesthesia. 15:74-5
    • Noronha V, Ramswamy A, Gattani SC, Krishnamurthy MN, Menon N, Patil V, Gota V, Banavali S, Prabhash K (2021). Polypharmacy and potentially inappropriate medication use in older Indian patients with cancer: A prospective observational study. Cancer Research Statistics and Treatment. 4(1): 67-73.
    • Ojha S, Tirlotkar A, Gupta AM, Sumathi SH, Chavan P, Poojary M (2020). Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature. Transfusion and Apheresis Science. 60:103014. PMID: 33262053
    • Pai T, Shet T, Patil A, Parmar V, Wadasadawala T, Sangeeta Desai S (2021). Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature. Human Pathology: Case Reports. 23: 200465.
    • Patil R, Gupta T, Maitre M, Dasgupta A, Sahay A, Epari S, Shirsat N, Chatterjee A, Krishnatry R, Goda JS, Moiyadi A, Patil V, Chinnaswamy G, Bano N, Jalali R (2021). Clinical Audit of Survival Outcomes and Prognostic Factors in Adolescents and Adults with Medulloblastoma. Journal of Adolescent and Young Adult Oncology.
    • Patil VM, Singhai P, Noronha V, Bhattacharjee A, Deodhar J, Salins N, Joshi A, Menon NS, Abhyankar A, Khake A, Dhumal SB, Tambe R, Muckaden MA, Prabhash K (2021). Effect of early palliative care on quality of life of advanced head and neck cancer patients: A phase III Trial. Journal of National Cancer Institute.PMID: 33606023
    • Patkar N, Kakirde C, Shaikh AF, Salve R, Bhanshe P, Chatterjee G, Rajpal S, Joshi S, Chaudhary S, Kodgule R, Ghoghale S, Deshpande N, Shetty D, Khizer SH, Jain H, Bagal B, Menon H, Khattry N, Sengar M, Tembhare P, Subramanian P, Gujral S (2021). Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). Leukemia. PMID: 33558666.
    • Pawar D, Chatterjee A, Epari S, Sahay A, Janu A, Krishantry R, Goda JS, Shetty P, Moiydai A, Gupta T (2021). Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit. Journal of Clinical Neurosciecne. 84:91-96. PMID: 33358093
    • Punatar S, Kalantri SA, Chichra A, Agrawal AK, Nayak L, Bonda A, Gokarn A, Bagal B, Mathew L, Kannan S, Khattry N (2021). Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes. Bone Marrow Transplantation.
    • Qureshi SS, Bhagat M, Smriti V, Murli D, Baheti A, Yadav S, Prasad M, Khanna N, Laskar S, Kembhavi S, Vora T, Chinnaswamy G, Amin N, Ramadwar M, Talole S (2020). Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes. Journal of Pediatric Urology. 17(1): 69.e1-69.e8. PMID: 33087302
    • Qureshi SS, Kazi M, Noronha J, Smriti V, Basu S, Shah S, Talole S (2021). Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers. Indian Journal of Surgical Oncology.
    • Rajendra A, Jain H, Bonda VNA, Nayak L, Tembhare P, Shetty D, Thorat J, Jain H, Subramanian PG, Patkar N, Chatterjee G, Khattry N, Gokarn A, Punatar S, Mokal S, Bagal B, Sengar M (2021). Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol. Blood Advances. 5(5):1178-1193. PMID: 33635331
    • Shabrish S, Mittra I(2021). Cytokine storm as a cellular response to dsDNA breaks: A new proposal. Frontiers in Immunology. 12:622738.
    • Shetty D, Talker E, Jain H, Patil S, Tembhare P, Patkar N, Nayak L, Jain H, Sengar M (2021). Additional Cytogenetic Aberrations Indicative of Poor Prognosis in AML with RUNX1/RUNX1T1 Rearrangement: Karyotype a Chromosomal Blueprint. Annals of Hematology and Oncology. 8(1): 1325.
    • Shetty D, Talker E, Jain H, Talker J, Patkar N, Subramanian P, Jain H, Bonda A, Punatar S, Gokarn A, Bagal B, Sengar M, Khattry N (2021). Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation. Asia Pacific Journal of Clinical Oncology. PMID: 33629824
    • Sinha S, Agarwal JP, Mahajan A, Chaturvedi P, Balaji A, Juvekar S, Gupta T, Budrukkar A, Murthy V, Mummudi N, Swain M, Jadhav R, Laskar SG (2021 Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study. Head Neck. 43(4):1289-1299. PMID: 33368793.
    • Sood S, Gurram L, Aravindakshan D, Paul J, Chopra S, Swamidas J, Patil A, Mahantshetty U (2021). Reporting of dose-volume specifications for "Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers" according to International Commission on Radiation Units and Measurements 58 with early clinical outcomes. Brachytherapy. PMID: 33648892
    • Swain M, Ghosh-Laskar S, Budrukkar A, Patil R, Murthy V, Gupta T, Mummudi N, Prabhash K, Joshi A, Patil VM, Naronha V, Agarwal JP (2021). Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute. European archives of oto-rhino-laryngologyl. PMID: 33564909.
    • Telkhade T, Murthy V, Kanala TS, Mathew JM, Phurailatpam R, Mokal S, Chourasiya D, Panigrahi G, Krishnatry R (2021). Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer. Clinical Oncology. 33(3):172-180. PMID: 33214044
    • Thekkeveettil M, Tandon S, Moiyadi A, Gujral S. Narula G (2020). Extramedullary Sarcoma of Brain With Extracranial Extension Mimicking a Primary Brain Tumor. Journal of Pediatric Hematology/Oncology. 43(1):e149-e151.PMID: 32852393
    • Thomas A, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Vaish R. Papillary and medullary thyroid carcinomas presenting as collision tumors: A case series of 21 cases at a tertiary care cancer center. Head and Neck Pathology. PMID: 33840044
    • Tripathy B, Pal K, Shabrish S, Mittra I (2021). A New perspective on the origin of DNA double-strand breaks and its implications for ageing. Genes. PMID: 33530310
    • Wadasadawala T, Sen S, Watekar R, Rane P, Sarin R, Gupta S, Parmar V, Kannan S, Mohanty SK (2021). Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study. Asian Pacific Journal Cancer Prevention. 22(3):793-800. PMID: 33773543
    • Kulkarni P, Mehta P, Shriyan B, Gawit K, Gota V, Ghante M. (2021) "Pharmacokinetics, Pharmacodynamics, and Toxicology Aspects of Immunotherapeutics". In: Sawarkar SP, Nikam VS, Syed S. (Eds.) Immunotherapy – A Novel Facet of Modern Therapeutics. Singapore Springer, 2021. Pp. 195-214. (ISBN: 978-981-15-9037-5)
    • Bandekar M, Maurya DK, Sharma D, Checker R, Gota V, Mishra N, Sandur SK (2020). Xenogeneic transplantation of Human WJ-MSCs rescues mice from acute radiation syndrome via Nrf2 dependent regeneration of damaged tissues. American Journal of Trasplantation. PMID: 32040239

    • Chopra S, Engineer R, Shah S, Shukla R, Dora T, Gupta P, Paul SN, Popat P, Swamidas J, Mahantshetty U, Varghese L, Gupta S, Rangrajan V, Shrivastava S. MRI and PET Guided Interstitial Brachytherapy for post-surgical vaginal recurrences of cervical cancer: Results of phase II study. International Journal of Radiation Oncology Biology Physics. 106(2): 310-319, 2020. PMID: 31682968

    • Gupta S, Aitken J, Bartels U, Bhakta N, Bucurenci M, Brierley JD, De Camargo B, Chokunonga E, Clymer J, Coza D, Fraser C, Fuentes-Alabi S, Gatta G, Gross T, Jakab Z, Kohler B, Kutluk T, Moreno F, Nakata K, Nur S, Parkin DM, Penberthy L, Pole J, Poynter JN, Pritchard-Jones K, Ramirez O, Renner L, Steliarova-Foucher E, Sullivan M, Swaminathan R, Van Eycken L, Vora T, Frazier AL. Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines. Lancet Oncology. 21(9): e444-e451. PMID: 32888473

    • Gupta T, Chatterjee A, Patil V (2020). Extended adjuvant temozolomide in newly-diagnosed glioblastoma: is more less? Neuro-Oncology. 22(12): 1887-1888. PMID: 32777076

    • Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A (2020). Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology. 77(4): 508-547. PMID: 32001144

    • Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R (2020). Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors. Neuro-Oncology. PMID: 32227185

    • Murthy V, Maitre P, Bhatia J, Kannan S, Krishnatry R, Prakash G, Bakshi G, Pal M, Menon S, Mahantshetty U (2020). Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial. Radiotherapy and Oncology. 145: 71-80. PMID: 31923712

    • Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Gefitinib Versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-Mutated lung cancer. Journal of Clinical Oncology. 38(2): 124-136. PMID: 31411950

    • Noronha V, Bhattacharjee A, Patil VM, Joshi A, Menon N, Shah S, Kannan S, Mukadam SA, Maske K, Ishi S, Prabhash K (2020). Aprepitant for cough suppression in advanced lung cancer: A randomized trial. Chest. 157(6): 1647-1655 PMID: 31958446

    • Ostwal V, Kapoor A , Mandavkar S, Chavan N, Gupta T, Mirani J, Saklani A, Desouza A, Shrinivasan K, Nashikkar C, Gupta S, Ramaswamy A (2020). Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study. Oncologist. 25(12): e1886-e1892. PMID: 32717127

    • Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, Iwata H, Mastura MY, Dent R, Lu YS, Yin Y, Smruti BK, Toyama T, Malwinder S, Lee SC, Tseng LM, Kim JH, Kim TY, Suh KJ, Cardoso F, Yoshino T, Douillard JY (2020). Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Annals of Oncology. 31(4):451-469. PMID: 32081575

    • Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, Tembhare P, Dhamne C, Prasad M, Moulik NR, Shetty D, Gokarn A, Bonda A, Nayak L, Punatkar S, Bagal B, Sengar M, Narula G, Khattry N, Banavali S, Subramanian PG, Gujral S (2020). NARASIMHA: Novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies. Blood Cancer Journal. 10(5): 50. PMID: 32372024

    • Raut A, Chopra S, Mittal P, Patil G, Mahantshetty U, Gurram L, Swamidas J, Ghosh J, Gulia S, Popat P, Deodhar K, Maheshwari A, Gupta S (2020). FIGO classification 2018: Validation study in patients with locally advanced cervix cancer treated with chemo-radiation. International Journal of Radiation Oncology, Biology Physics. PMID: 32681859

    • Swamidas J, Kirisits C, De Brabandere M, Hellebust TP, Siebert FA, Tanderup K (2020). Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy. Radiotherapy Oncology. 143: 1-11. PMID: 31564555
    • Berger T, Seppenwoolde Y, Pötter R, Assenholt MS, Lindegaard SJ, Nout R, Leeuw A, Jürgenliemk-Schulz I, Tee Tan L, Georg D, Kirisits C, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Fokdal L, Tanderup K (2019) - Importance of technique, target selection, contouring, dose prescription and dose-planning in external beam radiotherapy for cervix cancer: evolution of practice from EMBRACE-I to II. International Journal of Radiation Oncology, Biology, Physics. 104(4): 885-894. PMID: 30904706

    • Biswas NK, Das C, Das S, Maitra A, Nair S, Gupta T, D'Cruz AK, Sarin R, Majumder PP (2019) - Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects. International Journal of Cancer. 145(9): 2568-2579. PMID: 30924133

    • Chopra S, Deodhar K, Pai V, Pant S, Rathod N, Goda JS, Sudhalkar N, Pandey P, Waghmare S, Engineer R, Mahantshetty U, Ghosh J, Gupta S, Shrivastava S. Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study. International Journal of Radiation Oncology, Biology , Physics. 103(1): 161-168. PMID: 30213750

    • Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS, Jalali R (2019) - Nomograms based on pre-operative multi-parametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: Results from a radiogenomics study of 111 Patients. Neuro- Oncology. 21(1): 115-124. PMID: 29846693

    • Gandhi KA, Goda JS, Gandhi VV, Sadanpurwala A, Jain VK, Joshi K, Epari S, Rane S, Mohanty B, Chaudhari P, Kembhavi S, Kunwar A, Gota V, Priyadarsini KI (2019) - Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis. Free Radical Biology and Medicine.145: 8-19, PMID: 31521664

    • Jalali R, Goda JS (2019) - Proton beam therapy in pediatric brain tumor patients: Improved radiation delivery techniques improve neurocognitive outcomes. Neuro- Oncology. 21(7): 830-831. PMID: 31081892

    • Jha P, Kumar D, Dikshit R, Budukh A, Begum R, Sati P, Kolpak P, Wen R, Raithatha SJ, Shah U, Li ZR, Aleksandrowicz L, Shah P, Piyasena K, McCormick TH, Gelband H, Clark SJ (2019) - Automated versus physician assignment of cause of death for verbal autopsies: Randomized trial of 9374 deaths in 117 villages in India. BMC Medicine. 17(1): 116. PMID: 31242925

    • Mahantshetty U, Sturdza A, Pusha Naga CH, Berger D, Fortin I, Motisi L, Schmid MP, Aravindakshan D, Ghdi Y, Swamidas JV, Chopra S, Gurram L, Nescacil N, Kirisits C, Richard Pötter (2019) - Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Radiotherapy and Oncology. 141: 123-129, 2019. PMID: 31495516

    • Murthy V (2019) - International consensus for advanced bladder cancer: An opportunity between the lines. Annals of Oncology. 30(11): 1688-1690. PMID: 31750878

    • Murthy V, Johnny C, Huddart R (2019) - Positron Emission Tomography-positive post-chemotherapy seminoma masses: Time to reevaluate the role of radiotherapy? Journal of Clinical Oncology. 37(11): 937-938. PMID: 30811289

    • Page EC, Bancroft EK, Brook MN, Assel M, Hassan Al Battat M, Thomas S, Taylor N, Chamberlain A, Pope J, Raghallaigh HN, Evans DG, Rothwell J, Mahle L, Grindedal EMM, James P, Mascarenhas L, McKinley J, Side L, Thomas T, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Jensen TD, Osther PJS, Helfand BT, Genova E, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Lam J, Taylor L, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams W, Cook J, Rosario DJ, Domchek S, Powers J, Buys S, O'Toole K, Ausems MGEM, Schmutzler RK), Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, van Randeraad H, Davidson R, Longmuir M, Ruijs MWG, Helderman van den Enden ATJM, Adank M, Williams R, Andrews L, Murphy DG, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Morton C, Shackleton K, Snape K, Hanson H, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Ramon Y Cajal T, Zgajnar J, Brewer C, Gadea N, Brady AF, van Os T, Gallagher D, Johannsson O, Donaldson A, Barwell J, Nicolai N, Friedman E, Obeid E, Greenhalgh L, Murthy V, Copakova L, Saya S, McGrath J, Cooke P, Rønlund K, Richardson K, Henderson A, Teo SH, Arun B, Kast K, Dias A, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Eyfjord J, Falconer A, Foster C, Gronberg H, Hamdy FC, Stefansdottir V, Khoo V, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Moynihan C, Rennert G, Suri M, Wilson P, Dudderidge T, IMPACT Study Collaborators, Offman J, Kote-Jarai Z, Vickers A, Lilja H, Eeles RA (2019) - Interim results from the IMPACT study: Evidence for prostate-specific antigen screening in BRCA2 mutation carriers. European Urology. 76(6): 831-842. PMID: 31537406

    • Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhattacharjee A, Gota V, Pandey M, Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, D’souza H, Srinivas S, Kashyap L, Banavali S, Prabhash K (2019) - Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer. Journal of Clinical Oncology. 37(32): 3032-3041. PMID: 31539316

    • Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P (2019) - A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1. Blood Cancer Journal. 9(10): 79, PMID: 31575857
    • Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R (2018). Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: A randomized controlled trial. Journal of Clinical Oncology. 36(16): 1548-1555. PMID: 29432076

    • Kirolikar S, Prasannan P, Raghuram GV, Pancholi N, Saha T, Tidke P, Chaudhari P, Shaikh A, Rane B, Pandey R, Wani H, Khare NK, Siddiqui S, D'souza J, Prasad R, Shinde S, Parab S, Nair NK, Pal K, Mittra I (2018). Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death and Disease. 9(12): 1142. PMID: 30442925

    • Mahantshetty U, Naga P, Khadanga CR, Gudi S, Chopra S, Gurram L, Jamema S, Ghadi Y, Shrivastava S (2018). A prospective comparison of computerized-tomography (CT) based with trans-rectal-ultrasonography (TRUS) assistance and magnetic-resonance imaging (MRI) based target-volume definition during image guided adaptive brachytherapy for cervical cancers. International Journal of Radiation Oncology, Biology, Physics. 102(5): 1448-1456. PMID: 30146092

    • Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadaló L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K; IMPACT study collaborators, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA (2018). Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer. 118(2):266-276. PMID: 29301143

    • Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T. Role of radiation therapy in patients With relapsed/refractory diffuse large B-cell lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 100(3): 652-669, 2018. PMID: 29413279

    • Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K (2018). Once-a-Week versus Once-every-3-Weeks cisplatin chemoradiation for locally advanced head and neck Cancer: A phase III randomized noninferiority trial. Journal of Clinical Oncology. 10; 36(11): 1064-1072. PMID: 29220295

    • Sargos P, Baumann BC, Eapen L, Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V, Ballas L, Zaghloul M, Roubaud G, Orré M, Larré S (2018). Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy. Cancer Treatment Reviews. 70: 88-97. PMID: 30125800

    • Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh C-Ok, Mauch PM, Specht L, Yahalom J. Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics. 101(4): 794-808, 2018. PMID: 29976492
    • Gupta S, Mukherjee S, Syed P, Pandala NG, Choudhary S, Singh VA, Singh N, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2017). Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Oncotarget. 8(35): 58443-58456. PMID: 28454087

    • Mahantshetty U, Krishanty R, Hande V, Jamema S, Ghadi Y, Engineer R, Chopra S, Naidu L, Deshpande D, Shrivastava S. Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: An experience from a tertiary cancer centre in a low-middle income country setting. International Journal of Radiation Oncology, Biology, Physics. 99(3): 608-617

    • Mittra I, Pal K, Pancholi N, Shaikh A, Rane B, Tidke P, Kirolikar S, Khare NK, Agrawal K, Nagare H, Nair NK (2017). Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin. Annals of Oncology. 28(9): 2119-2127. PMID: 28911066

    • Prabhu S, Goda JS, Mutalik S, Mohanty BS, Chaudhari P, Rai S, Udupa N, Rao BSS (2017). A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: Tumor-specific homing directed by nestin. Nanoscale. 9(30): 10919-10932. PMID: 28731079

    • Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, Colleoni M, Tondini C, Pinotti G, Salim M, Spazzapan S, Parmar V, Ruhstaller T, Abdi EA, Gelber RD, Coates AS, Goldhirsch A, Pagani O (2017). Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT. Annals of Oncology. 28(9): 2225-2232. PMID: 28911092

    • Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, Bernhard J, Luo W, Gómez HL, Burstein HJ, Parmar V, Torres R, Stewart J, Bellet M, Perelló A, Dane F, Moreira A, Vorobiof D, Nottage M, Price KN, Coates AS, Goldhirsch A, Gelber RD, Colleoni M, Fleming GF (2017). Treatment efficacy, adherence, and quality of life among women younger than 35 years in the International Breast Cancer Study Group TEXT and SOFT adjuvant endocrine therapy trials. Journal of Clinical Oncology. 35(27): 3113-3122, 2017.PMID: 28654365
    • Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn S-M, Ahn J-H, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young M-A, Sarin R, Blay J-Y, Seán, O'Donoghue I, Thomas DM (2016). Monogenic and polygenic determinants of sarcoma risk: An international genetic study. Lancet Oncol. 17(9): 1261-1271, 2016. PMID: 27498913

    • Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B, Philley JV, Sauter ER, Ikebe M, Idell S, Gupta S, Dasgupta S (2016). Mitochondrial Reprogramming Regulates Breast Cancer Progression. Clinical Cancer Research. 22(13): 3348-60. PMID: 26888829.

    • Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffeta P, Gupta S, Parmar V, Badwe R, Dikshit R (2016). Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. European Journal of Cancer. 66: 153-161. PMID: 27573429
    • Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S (2015). Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: An open-label randomised controlled trial. Lancet Oncology. 16:1380-1388. PMID: 26363985

    • D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015). Head and Neck Disease Management Group. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. New England Journal of Medicine. 373: 521-529. PMID: 26027881

    • Suryavanshi S, Sharma D, Checker R, Thoh M, Gota V, Sandur SK, Sainis KB (2015). Amelioration of radiation induced hematopoietic syndrome by an antioxidant chlorophyllin through increased stem cell activity and modulation of haematopoiesis . Free Radical Biology and Medicine. 85: 56-70.PMID: 25872101

    • Syed P, Gupta S, Choudhary S, Pandala NG, Atak A, Richharia A, Kp M, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2015). Autoantibody profiling of glioma serumsamples to identify biomarkers using human proteome arrays. Scientific Reports. PMID: 26370624

    • Venkitaraman R, Lorente D, Murthy V, Thomas K, Parker L, Ahiabor R, Dearnaley D, Huddart R, De Bono J, Parker C (2015).A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer.European Urology. 67(4): 673-679. PMID: 25457497
Back to Top